Market Tracker

12/17 6:05pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

87.21
Data as of Dec 17
 +1.15 / +1.34%
Today’s Change
55.04
Today|||52-Week Range
96.36
+23.97%
Year-to-Date

Today’s Trading

Previous close86.06
Today’s open86.34
Day’s range85.72 - 87.83
Volume1,575,123
Average volume (3 months)1,205,485
Market cap$12.7B
Dividend yield--
Data as of 3:59pm ET, 12/17/2014

Growth & Valuation

Earnings growth (last year)-34.74%
Earnings growth (this year)+18.39%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+10.82%
P/E ratioNM
Price/Sales17.67
Price/Book9.21

Competitors

 Today’s
change
Today’s
% change
INCYIncyte Corp+3.96+5.53%
MNKMallinckrodt Plc+1.87+2.05%
ENDPEndo International P...+1.86+2.75%
HSPHospira Inc+1.43+2.43%
Data as of 4:06pm ET, 12/17/2014

Financials

Next reporting dateFebruary 19, 2015
EPS forecast (this quarter)-$0.60
Annual revenue (last year)$548.4M
Annual profit (last year)-$176.4M
Net profit margin-32.15%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Daniel K. Spiegelman
Corporate headquarters
San Rafael, California

Forecasts